Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Enzalutamide”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04335682
What this trial is testing

Androgen Receptor Directed Therapy on Cognitive Function in Patients Treated With Darolutamide or Enzalutamide

Who this might be right for
Metastatic Prostate CancerProstate Cancer MetastaticProstate Cancer+3 more
Alliance Foundation Trials, LLC. 111
Testing effectiveness (Phase 2)Study completedNCT02684227
What this trial is testing

Enzalutamide, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrioid Endometrial Cancer

Who this might be right for
Recurrent Endometrial Endometrioid AdenocarcinomaRecurrent Uterine Corpus CarcinomaStage III Uterine Corpus Cancer AJCC v7+6 more
M.D. Anderson Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT02507570
What this trial is testing

Open Label Phase Two Study of Enzalutamide With Concurrent Administration of Radium Ra 223 Dichloride in Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Symptomatic Bone Metastasis

Who this might be right for
Prostate Carcinoma Metastatic to the Bone
Carolina Research Professionals, LLC 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT02522715
What this trial is testing

Enzalutamide and Cabazitaxel in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate CarcinomaRecurrent Prostate Carcinoma+1 more
OHSU Knight Cancer Institute 37
Testing effectiveness (Phase 2)Study completedNCT02278185
What this trial is testing

Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage III Prostate Cancer+1 more
University of Colorado, Denver 19
Early research (Phase 1)Active Not RecruitingNCT02023463
What this trial is testing

Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage IIB Prostate Cancer+2 more
Thomas Jefferson University 25
Large-scale testing (Phase 3)WithdrawnNCT02929576
What this trial is testing

Efficacy and Safety Study of Enzalutamide in Combination With Paclitaxel Chemotherapy or as Monotherapy Versus Placebo With Paclitaxel in Patients With Advanced, Diagnostic-Positive, Triple-Negative Breast Cancer

Who this might be right for
Breast Cancer
Pfizer
Early research (Phase 1)Study completedNCT04094519
What this trial is testing

Evaluate the Effect of Multiple Doses of Enzalutamide on the Pharmacokinetics of Substrates of P-glycoprotein (Digoxin) and Breast Cancer Resistant Protein (Rosuvastatin) in Male Subjects With Prostate Cancer

Who this might be right for
Prostate Cancer
Astellas Pharma Global Development, Inc. 24
Testing effectiveness (Phase 2)Ended earlyNCT01885949
What this trial is testing

Tivozanib + Enzalutamide in Adv Prostate Cancer

Who this might be right for
Prostate Cancer
Massachusetts General Hospital 5
Early research (Phase 1)Ended earlyNCT03478904
What this trial is testing

Study to Compare Capsule and Liquid Formulations of Enzalutamide After Single Dose Administration Under Fasting Conditions in Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 1
Testing effectiveness (Phase 2)Ended earlyNCT04052204
What this trial is testing

Avelumab With Bempegaldesleukin With or Without Talazoparib or Enzalutamide in Advanced or Metastatic Solid Tumors

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck (SCCHN)Metastatic Castration Resistant Prostate Cancer (mCRPC)
Pfizer 3
Large-scale testing (Phase 3)Ended earlyNCT04237584
What this trial is testing

A Study Comparing ARB With Radium-223 vs ARB Therapy With Placebo and the Effect Upon Survival for mCRPC Patients

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
MANA RBM 23
Early research (Phase 1)Study completedNCT02991911
What this trial is testing

A Phase 1/1b Study of MEDI3726 in Adults Subjects With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
MedImmune LLC 33
Testing effectiveness (Phase 2)UnknownNCT06015321
What this trial is testing

An Open Label Phase II Study of First-Line Maintenance Enzalutamide Following Docetaxel Plus Androgen-Deprivation Therapy in Patients With Previously-Untreated, Metastatic, Castration-Naive Prostatic Adenocarcinoma

Who this might be right for
Prostatic Adenocarcinoma
Samsung Medical Center 51
Testing effectiveness (Phase 2)Study completedNCT02346578
What this trial is testing

Comparative Study of Alternative Antiandrogen (AA) Therapy and Early Initiating of Enzalutamide for Castration-resistant Prostate Cancer (CRPC) After Combined Androgen Blockade (CAB) Therapy.

Who this might be right for
Castration-resistant Prostate Cancer
Taro Iguchi, MD, PHD 104
Post-approval studies (Phase 4)Study completedNCT03641560
What this trial is testing

A Safety and Efficacy Study of Enzalutamide in Indian Patients With Progressive Metastatic Castration-Resistant Prostate Cancer (mCRPC) Previously Treated With Docetaxel-Based Chemotherapy

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Astellas Pharma Inc 52
Testing effectiveness (Phase 2)Study completedNCT02384382
What this trial is testing

A Positron Emission Tomography/Computed Tomography (PET/CT) Bone Imaging Study in Patients Receiving Enzalutamide for Castration-Resistant Prostate Cancer (CRPC)

Who this might be right for
Prostate Carcinoma Metastatic to the BoneCastration Resistant Prostate Cancer
Pfizer 23
Not applicableStudy completedNCT06072196
What this trial is testing

Learn About Novel Hormonal Therapies in People With Metastatic Castration-Sensitive Prostate Cancer (mCSPC)

Who this might be right for
Prostatic Neoplasms
Pfizer 3,017
Testing effectiveness (Phase 2)Study completedNCT03336983
What this trial is testing

Luteinizing Hormone-releasing Hormone Analogue and Enzalutamide +/- Zoledronic Acid in Prostate Cancer Patients

Who this might be right for
Prostate CancerBone Metastases
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 126
Testing effectiveness (Phase 2)Study completedNCT03314324
What this trial is testing

Patient Preference Between ODM-201 and Enzalutamide in Men With Metastatic Castrate-resistant Prostate Cancer

Who this might be right for
Metastatic Castrate-resistant Prostate (CRPC) Cancer
Gustave Roussy, Cancer Campus, Grand Paris 250
Next Page